BioCentury
ARTICLE | Company News

Ligand, Schering-Plough deal

August 10, 2009 7:00 AM UTC

Ligand and Schering-Plough's Organon N.V subsidiary mutually ended a 2007 deal to discover, develop and commercialize compounds for indications including neuroscience and immunology. Organon is respon...